Clinical Trial Update: A Phase I Clinical Trial of a mRNA Vaccine for Recurrent or Progressive High-grade Glioma [Phase 1]

View source ↗

Summary

This update describes a Phase I clinical trial of an mRNA vaccine for recurrent or progressive high-grade glioma that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• High-grade Glioma

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Glioma, High Grade | Phase 1 | Status: RECRUITING